Autolus Therapeutics plc
AUTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $227 | $240 | $382 | $310 |
| Short-Term Investments | $361 | $0 | $0 | $0 |
| Receivables | $48 | $1 | $29 | $0 |
| Inventory | $4 | $0 | $0 | $0 |
| Other Curr. Assets | $21 | $35 | $14 | $37 |
| Total Curr. Assets | $661 | $275 | $426 | $347 |
| Property Plant & Equip (Net) | $105 | $96 | $58 | $52 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $12 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $3 | $3 | $2 | $0 |
| Other NC Assets | $1 | $1 | $4 | $6 |
| Total NC Assets | $122 | $100 | $65 | $59 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $783 | $375 | $490 | $406 |
| Liabilities | – | – | – | – |
| Payables | $2 | $0 | $1 | $0 |
| Short-Term Debt | $3 | $5 | $5 | $4 |
| Tax Payable | $4 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $52 | $40 | $41 | $24 |
| Total Curr. Liab. | $61 | $45 | $46 | $29 |
| LT Debt | $50 | $48 | $19 | $64 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $245 | $171 | $126 | $0 |
| Total NC Liab. | $295 | $219 | $145 | $64 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $53 | $53 | $24 | $21 |
| Total Liabilities | $355 | $264 | $192 | $92 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,099 | -$879 | -$670 | -$521 |
| AOCI | -$29 | -$29 | -$39 | -$8 |
| Other Equity | $1,556 | $1,019 | $1,008 | $843 |
| Total Equity | $427 | $111 | $299 | $313 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $783 | $375 | $490 | $406 |
| Net Debt | -$175 | -$187 | -$358 | -$242 |